Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Galmed Pharmaceuticals Ltd. buy Wells Fargo & Company

Start price
€6.40
06.11.24 / 50%
Target price
€81.94
06.11.25
Performance (%)
-
End price
-
07.11.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Galmed Pharmaceuticals Ltd. - - -
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Wells_Fargo___Compan for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Buy
Perf. (%) -
Target price 81.937
Change
Ends at 06.11.25

Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Company from $78.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat

In the thread Trading Galmed Pharmaceuticals Ltd.
Prediction Buy
Perf. (%) -
Target price 81.937
Change
Ends at 06.11.25

Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten

Current prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
21.02.25
€88.72
21.02.26
-
19.09.24

Stopped prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
07.11.25
€68.47
07.11.26
-
19.09.24

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
08.08.25
€56.60
08.08.26
-
19.09.24

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
11.12.24
€90.54
11.12.25
-
12.12.25